People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vytalyx Inc | — | Pharmaceuticals | Series C | $88.4M | $2.1B | 2017 |
David P Valenti at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David P Valenti on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Alexander Granzotti | 1 | 2 |
| Jennifer Silvio Tanguy | 1 | 1 |
| David Silvio Valenti | 1 | 1 |
| Jeffrey Silvio Heller | 1 | 1 |
| Dave Silvio Wentz | 1 | 1 |
| John Silvio Hartwig | 1 | 1 |
| Andre Silvio Granzotti | 1 | 1 |
| Gary Silvio Pike | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.